IE791069L - Thiazole derivatives - Google Patents

Thiazole derivatives

Info

Publication number
IE791069L
IE791069L IE791069A IE106979A IE791069L IE 791069 L IE791069 L IE 791069L IE 791069 A IE791069 A IE 791069A IE 106979 A IE106979 A IE 106979A IE 791069 L IE791069 L IE 791069L
Authority
IE
Ireland
Prior art keywords
thiazole
phenethylamino
phenyl
thenylamino
thiazole derivatives
Prior art date
Application number
IE791069A
Other versions
IE48426B1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IE791069L publication Critical patent/IE791069L/en
Publication of IE48426B1 publication Critical patent/IE48426B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16BDEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
    • F16B15/00Nails; Staples
    • F16B15/0023Nail plates
    • F16B2015/0076Nail plates with provisions for additional fastening means, e.g. hooks, holes for separate screws or nails, adhesive

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A series of 2-aryl aminothiazoles and the pharmaceutically acceptable acid addition salts thereof having anti- antiflammatory and immune regulant activity are disclosed. Preferred compounds include 2- phenethylamino-4-phenyl-thiazole, 2- phenethylamino-4,5-diphenyl- thiazole, 5-methyl-2-phenethylamino- 4-phenyl-thiazole, 2-thenylamino-4- phenyl-thiazole and 2-thenylamino-4- (p-fluorophenyl)thiazole. [GB2022085A]
IE1069/79A 1978-06-02 1979-08-08 Novel aminothiazoles IE48426B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91183078A 1978-06-02 1978-06-02

Publications (2)

Publication Number Publication Date
IE791069L true IE791069L (en) 1979-12-02
IE48426B1 IE48426B1 (en) 1985-01-23

Family

ID=25430923

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1069/79A IE48426B1 (en) 1978-06-02 1979-08-08 Novel aminothiazoles

Country Status (36)

Country Link
JP (1) JPS5936988B2 (en)
AR (1) AR226285A1 (en)
AT (1) AT373248B (en)
AU (1) AU511242B2 (en)
BE (1) BE876732A (en)
CA (1) CA1117949A (en)
CH (1) CH639653A5 (en)
CS (1) CS216927B2 (en)
DD (1) DD144055A5 (en)
DE (1) DE2922523C2 (en)
DK (1) DK150068C (en)
EG (1) EG14354A (en)
ES (1) ES481220A1 (en)
FI (1) FI68820C (en)
FR (1) FR2427333A1 (en)
GB (1) GB2022085B (en)
GR (1) GR73142B (en)
HK (1) HK66487A (en)
HU (1) HU180045B (en)
IE (1) IE48426B1 (en)
IL (1) IL57450A (en)
IT (1) IT1121238B (en)
KE (1) KE3459A (en)
LU (1) LU81349A1 (en)
MY (1) MY8500318A (en)
NL (1) NL178421C (en)
NO (1) NO150760C (en)
NZ (1) NZ190623A (en)
PH (1) PH17020A (en)
PL (1) PL117515B1 (en)
PT (1) PT69718A (en)
SE (1) SE438333B (en)
SG (1) SG56184G (en)
SU (1) SU843746A3 (en)
YU (1) YU40997B (en)
ZA (1) ZA792729B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982001481A1 (en) * 1980-10-24 1982-05-13 Ronald P Hansen Dust mitigation system
US4511574A (en) * 1981-01-08 1985-04-16 Mitsui Toatsu Kagaku Kabushiki Kaisha N-(4-Phenyl-2-thiazolyl)carbamate derivatives
JPS57136579A (en) * 1981-01-21 1982-08-23 Mitsui Toatsu Chem Inc Thiazolylurea derivative, its preparation, and pharmaceutical composition containing the same
JPS57116067A (en) * 1981-01-12 1982-07-19 Sankyo Kagaku Kk Novel 8-quinolinesulfonyl derivative, its synthesis and use
WO1982002386A1 (en) * 1981-01-13 1982-07-22 Sakano Isao Aminothiazole derivatives,process for their preparation,and medicinal composition containing same
WO1982002383A1 (en) * 1981-01-13 1982-07-22 Sakano Isao Novel thiazole compounds,process for their preparation,and medicinal composition containing same
JPS57154175A (en) * 1981-03-16 1982-09-22 Mitsui Toatsu Chem Inc 2-thiazoleamine derivative, its preparation, and drug composition comprising it
DE3227329A1 (en) * 1982-07-22 1984-01-26 Basf Ag, 6700 Ludwigshafen METHOD FOR PRODUCING 2-N, N-DISUBSTITUTED AMINOTHIAZOLES
WO1986003203A1 (en) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Thienylthiazole derivatives
FR2581063B1 (en) * 1985-04-30 1987-07-17 Chauvin Blache Lab AMINO-2 THIAZOLES N-SUBSTITUTED, THEIR PREPARATION PROCESS AND THEIR APPLICATION IN THERAPEUTICS
JPS63152368A (en) * 1986-06-03 1988-06-24 Sumitomo Pharmaceut Co Ltd Novel aminoazole derivative and acid addition salt thereof
JPH075579B2 (en) * 1986-09-01 1995-01-25 吉富製薬株式会社 Aminothiazole compound
JPH0753666B2 (en) * 1987-09-14 1995-06-07 久光製薬株式会社 Anti-inflammatory agent consisting of substituted diphenylthiazole derivative
ES2111540T3 (en) * 1989-08-10 1998-03-16 Commw Scient Ind Res Org METHOD FOR THE PRODUCTION OF A MICROPARTICLE ELECTROSUSPENSION.
AU654125B2 (en) * 1991-03-07 1994-10-27 Hisamitsu Pharmaceutical Co., Inc. Novel diphenylthyazole derivative
FR2692893B1 (en) * 1992-06-24 1994-09-02 Sanofi Elf Branched alkylamino thiazole derivatives, processes for their preparation and pharmaceutical compositions containing them.
WO1996003392A1 (en) * 1994-07-27 1996-02-08 G.D. Searle & Co. Substituted thiazoles for the treatment of inflammation
FR2754258B1 (en) 1996-10-08 1998-12-31 Sanofi Sa AMINOTHIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE414079T1 (en) 2000-03-01 2008-11-15 Janssen Pharmaceutica Nv 2,4-DISUBSTITUTED THIAZOLYL DERIVATIVES
EP1423113A4 (en) * 2001-08-13 2007-04-18 Phenex Pharmaceuticals Ag Nr1h4 nuclear receptor binding compounds
WO2003027094A2 (en) * 2001-09-26 2003-04-03 Bayer Pharmaceuticals Corporation Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
RU2330839C2 (en) 2002-01-11 2008-08-10 Санкио Компани, Лимитед Amino alcohol derivatives or phosphoric acid derivatives and pharmaceutical compositions containing specified derivatives
EP1555264A1 (en) * 2004-01-15 2005-07-20 Sireen AG Five-membered heterocyclic compounds as inhibitors of SRC family protein kinase.
TWI355934B (en) 2004-02-24 2012-01-11 Sankyo Co Pharmaceutical composition for treatment or prophy
SG159561A1 (en) 2005-05-09 2010-03-30 Achillion Pharmaceuticals Inc Thiazole compounds and methods of use
CN101421265A (en) 2006-01-18 2009-04-29 安姆根有限公司 Thiazole compounds as protein kinase b (pkb) inhibitors
AU2008276521B2 (en) 2007-07-17 2011-11-03 Amgen Inc. Heterocyclic modulators of PKB
WO2009011871A2 (en) 2007-07-17 2009-01-22 Amgen Inc. Thiadiazole modulators of pkb
US20130143927A1 (en) * 2011-06-10 2013-06-06 Calcimedica, Inc. Compounds that modulate intracellular calcium
US20120316182A1 (en) 2011-06-10 2012-12-13 Calcimedica, Inc. Compounds that modulate intracellular calcium
US9856240B2 (en) 2011-10-19 2018-01-02 Calcimedica, Inc. Compounds that modulate intracellular calcium
CN110590785B (en) * 2019-09-23 2021-02-02 武汉大学 A kind of aminothiazole compound and its preparation method and application of anti-enterovirus type 71

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458526A (en) * 1966-09-26 1969-07-29 Upjohn Co Certain 2-amino-4,5-bis(p-methoxyphenyl)thiazoles

Also Published As

Publication number Publication date
BE876732A (en) 1979-12-03
DE2922523C2 (en) 1982-10-21
DD144055A5 (en) 1980-09-24
KE3459A (en) 1984-10-12
JPS54160369A (en) 1979-12-19
FR2427333A1 (en) 1979-12-28
EG14354A (en) 1984-06-30
GB2022085B (en) 1983-01-12
AT373248B (en) 1983-12-27
DK150068B (en) 1986-12-01
GR73142B (en) 1984-02-09
PL117515B1 (en) 1981-08-31
PT69718A (en) 1979-07-01
CH639653A5 (en) 1983-11-30
CS216927B2 (en) 1982-12-31
IL57450A0 (en) 1979-09-30
NL178421B (en) 1985-10-16
NO150760B (en) 1984-09-03
MY8500318A (en) 1985-12-31
FI791754A7 (en) 1979-11-26
NL7904337A (en) 1979-12-04
YU40997B (en) 1986-10-31
AU511242B2 (en) 1980-08-07
FR2427333B1 (en) 1983-05-20
SU843746A3 (en) 1981-06-30
FI68820B (en) 1985-07-31
JPS5936988B2 (en) 1984-09-06
SE7904798L (en) 1979-12-03
AU4763479A (en) 1979-12-06
IT7923228A0 (en) 1979-06-01
NO791831L (en) 1979-12-04
ATA401679A (en) 1983-05-15
SE438333B (en) 1985-04-15
IL57450A (en) 1982-11-30
DK150068C (en) 1987-06-29
IT1121238B (en) 1986-03-26
DK177679A (en) 1979-12-03
HK66487A (en) 1987-09-25
CA1117949A (en) 1982-02-09
FI68820C (en) 1985-11-11
DE2922523A1 (en) 1979-12-06
LU81349A1 (en) 1979-12-07
ZA792729B (en) 1981-03-25
NL178421C (en) 1986-03-17
GB2022085A (en) 1979-12-12
IE48426B1 (en) 1985-01-23
AR226285A1 (en) 1982-06-30
ES481220A1 (en) 1980-09-01
NO150760C (en) 1984-12-12
NZ190623A (en) 1984-07-06
HU180045B (en) 1983-01-28
PL216030A1 (en) 1980-03-10
YU128879A (en) 1982-10-31
PH17020A (en) 1984-05-11
SG56184G (en) 1985-03-08

Similar Documents

Publication Publication Date Title
GB2022085A (en) Novel Aminothiazoles
NO166184C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE N9-CYCLOPENTYL-SUBSTITUTED ADENIN DERIVATIVES.
NO156785B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CYCLOBUTAN DERIVATIVES.
NO167572C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF A THERAPEUTIC ACTIVE PURINE DERIVATIVE.
NO155347C (en) ANALOGUE PROCEDURE FOR PREPARING A THERAPEUTIC ACTIVE (6R, 7R) -7 - ((Z) -2- (2-AMINO-TIAZOL-4-YL) -2- (2-CARBOXY-PROP-2-OXYIMINO) -ACETAMIDO) -3- (1-pyridiniummethyl) CEF 3-em-4-carboxylate.
IE781878L (en) Imidazole derivatives
NO164025C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-IMIDAZOLYLMETHYL-TETRAHYDROCARBAZOLONE DERIVATIVES.
AU1266288A (en) Novel thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions
PT68511A (en) Process for the preparation of a d-alpha-amino- (p-hydroxyphenyl)-acetamido group containing penicillanic acid and cephalosporanic acid derivatives.
NO161497C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 9A-AZA-9A-HOMOERYTROMYCIN DERIVATIVES.
AU590375B2 (en) Aqueous formulation of 1,2-benzisothiazolin-3-one
NO164541C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZIMIDAZOLD DERIVATIVES.
IE46153L (en) Oxazinoazetidine compounds
AU527896B2 (en) Preparation of halomethyl esters of penicillanic acid 1,1-dioxide
NO159090C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDOINDOL DERIVATIVES.
AU4820679A (en) Derivatives of 1,3,5-triazacycloheptane-2,4-dione
NO165594C (en) ANALOGUE PROCEDURE FOR PREPARING BETA-LACTAMASE-INHIBITING PENICILLANIC ACID DERIVATIVES.
AU5354079A (en) 1,3,4-thiadiazole-2-carboxylic acid derivatives
NO162188C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOKINOLINES.
AU4910179A (en) 2-phenyl-amino-imidazoline (2) derivatives possessing bradycardiac activity
AU4864379A (en) Pyridoxine derivatives
IE810059L (en) Preparation of a thiazole derivative
AU527621B2 (en) Derivatives of 2-imino 2-(2-tritylamino 4-thiazolyl) acetic acid
NO163777C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DIOXINO (4,5-C) -PYRIDINE DERIVATIVES.
IE810311L (en) Guanylamidines.